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Getting to More Effective Weight
Management in Antipsychotic-Treated Youth:
A Survey of Barriers and Preferences
Ginger Nicol, MD,1 Elizabeth Worsham, MD,2 Debra Haire-Joshu, PhD,3 Alexis Duncan, PhD,4
Julia Schweiger, CCRC,5 Michael Yingling, MS,6 and Eric Lenze, MD7
Abstract
Background: Mentally ill youth are at risk for developing obesity, especially when they require antipsychotic treatment; more-
over, they may face unique challenges in adhering to behavioral weight loss interventions. The aims of this project were to
characterize the challenges families of youth with psychiatric disorders face when engaging in weight loss treatment and to gather
information on attitudes and preferences for weight management interventions in this population.
Methods: We devised a telephone survey to evaluate caregiver-perceived barriers/challenges to and preferences for behavioral
weight loss treatment in overweight or obese mentally ill youth ages 6–18 treated with an antipsychotic agent in an outpatient setting.
Results: A total of 26 parents or primary caregivers completed the survey. The most commonly cited barriers to participation in
physical activity (PA) and maintaining a healthy diet were child’s dislike of PA and child’s preference for energy-dense foods,
respectively, which were impacted by psychiatric symptoms. Preferences for weight loss treatment included individualized, pre-
scribed meal plans and shopping lists, and exercise support/demonstration, with a preference for Internet or cell phone applications to
help with monitoring food intake and exercise.
Conclusions: These results suggest that targets for obesity treatment in this population include individualized, specific support that
takes into account the child’s motivation, which is effected by psychiatric symptoms. Tools for providing support may include the
use of telehealth visits and mobile device applications for self-monitoring.
Introduction
B
etween 41% and 50% of individuals with serious
mental illnesses are obese.1 On average, mentally ill
individuals lose 25–30 years of life as a result of
obesity-related illnesses, including diabetes and cardio-
vascular disease (CVD).2 Higher rates of obesity in this
population are, in part, attributable to antipsychotic treat-
ment, which has well-established effects on adiposity and
glucose regulation.3 Thus, the National Institute of Dia-
betes and Digestive and Kidney Diseases (NIDDK) has
identified individuals with mental illness, including those
treated with antipsychotic medications, as a ‘‘special pop-
ulation’’ at increased risk for the development of obesity,
diabetes, and CVD.4 The prevalence of type 2 diabetes
(T2D) among youth in the general population is 0.46 per
1000 youth,5 with the majority of new-onset cases ex-
plained by high weight.6 Youth who are treated with anti-
psychotic agents experience significant treatment-related
weight gain7 and are 2–3 times more likely to develop T2D
than youth in the general population.5,6,8–10 Antipsychotic
medications are commonly used in youth to manage irri-
tability and aggression across a range of psychiatric diag-
noses, such as attention deficit hyperactivity disorder
(ADHD), autism, and mood disorders.11 Antipsychotic
treatment in youth is associated with severe behavioral
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symptoms and more frequent acute psychiatric care epi-
sodes than are experienced by non-antipsychotic-treated
mentally ill youth, suggesting that antipsychotic treat-
ment may be an indicator of illness severity.12 Although
discontinuation of antipsychotic medications can lead to
weight loss, this may occur at the expense of disabling
symptom recurrence.13 Given that antipsychotic discon-
tinuation may not be a feasible option for many youth taking
these medications, methods to mitigate treatment-related
weight gain are necessary.
Lifestyle interventions to promote healthy behaviors are
a first-line treatment recommendation for pediatric obesi-
ty.14 Therefore, it follows that behavioral intervention
should also be the starting point for addressing high weight
in youth treated with antipsychotic medications. However,
rates of treatment nonadherence in behavioral weight loss
interventions can be as high as 50% in non–mentally ill
individuals.15 Reasons for attrition in behavioral weight
loss treatment studies include psychosocial and socioeco-
nomic factors,16 which may be more prevalent in mentally
ill individuals. Nonetheless, adult weight management
programs located within community mental health clinic
settings have been successfully implemented.17–19 Al-
though the available evidence base in this area is limited, a
small number of studies suggest that factors specifically
related to psychiatric illness, including behavioral symp-
toms (e.g., social anxiety, paranoia, and lack of initiative),
medication effects (sedation and excessive weight gain
preventing physical mobility), and lack of transportation or
social support often prevent mentally ill adults from en-
gaging in weight loss treatment.20,21 Programming that in-
creases health knowledge and that offers social engagement
and daily structure is cited as promoting engagement in
behavioral weight loss programs.22
There have been no published reports of behavioral
weight loss interventions in antipsychotic treated youth,
and no data are available regarding the preferences for and
barriers to participating in behavioral weight loss inter-
ventions in this uniquely at-risk population. However,
studies of barriers to participation in and preferences for
weight loss treatment in non–mentally ill obese youth can
offer useful information. Pediatric behavioral weight loss
interventions that focus only on parents and parent behav-
iors have been shown to be at least as successful as family-
based interventions,23 suggesting that caregiver preferences
for weight loss treatment are an important aspect of treat-
ment adherence in non–mentally ill youth. Parents report
that a child’s lack of internal motivation is a primary rea-
son for treatment nonadherence.24 Parent-level barriers
include pragmatic issues, such as cost, transportation, and
appointment availability; parents also cite a lack of align-
ment with the provider regarding the goals of treatment as a
barrier.16,25 Predictors of treatment nonadherence in pedi-
atric behavioral weight loss studies include lack of intrin-
sic motivation to change health behaviors and pragmatic
challenges preventing families from attending visits.16,26
Taken together, these points might suggest that obese youth
with psychiatric disorders have more innate barriers to
treatment adherence than do their non–mentally ill coun-
terparts. Information regarding preferences and barriers
specific to this population is needed in order to determine
whether a modified approach is needed to enhance treat-
ment participation in this population.
To characterize the most common self-reported barriers
to participating in a behavioral weight management pro-
gram for families of children with a psychiatric illness, we
interviewed parents or adult caregivers of youth who were
treated with antipsychotic agents and had a documented
BMI in the overweight or obese range (‡85th percentile for
sex and age). A secondary aim was to obtain descriptive
information on attitudes and preferences toward weight
management interventions in parents or adult caregivers of
youth treated with antipsychotic agents. Our ultimate goal
was to describe barriers to and preferences for behavioral
weight loss treatment in families of youth treated with
antipsychotic medications.
Methods
Participants
Eligible participants were parents or legal guardians of
(1) patients attending the university outpatient child psy-
chiatry clinic or (2) participants in psychiatric clinical re-
search at the university ages 6–18 who were continuously
treated with antipsychotic medications between December
1, 2012 and December 31, 2013, and who had a docu-
mented BMI percentile >85 for age and sex, calculated
using the Epi Info software that was developed by the
CDC.27 BMI percentile was taken from the most recent
appointment in the medical record, and BMI trend over the
defined study period was assessed to confirm that weight
gain occurred during antipsychotic treatment. Contact in-
formation for the primary adult caregiver, listed as the
guarantor of health insurance, was also obtained from the
medical record. The listed guarantor was contacted by
phone and provided verbal informed consent to participate
in the study. If another adult caregiver was determined to
be the primary caregiver for the child, that individual was
contacted by phone and provided verbal informed consent
to participate in the study.
Barriers and Preferences Survey
We created a semistructured survey instrument to eval-
uate parent or caregiver barriers/challenges to and prefer-
ences for behavioral weight management treatment in
obese youth treated with an antipsychotic medication.
Questions were generated based on a review of existing
research regarding adult or parent/caregiver preferences
and barriers to participation in weight loss programs15,16,28
and in mental health treatment,29 the research team’s pre-
vious experience working with obesity and metabolic
disorders in mentally ill populations, and consultation with
experts in community behavioral obesity treatment and
in dissemination-implementation research methodology.
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Open-ended questions were based on prompts developed
during pilot testing (e.g., for reported barriers, examples
included ‘‘too difficult to participate based on psychiatric
symptoms such as irritability or anxiety’’ or ‘‘too difficult
to participate based on logistic challenges such as ap-
pointment time availability or transportation’’) or ‘‘other.’’
The survey addressed several domains related to behav-
ioral weight loss treatment experiences and utilization and
was pilot tested (for feasibility and clarity) with families
who were currently participating in a behavioral weight
loss intervention study funded by the National Institute of
Mental Health (NIMH).
The final instrument was comprised of 37 questions di-
vided into three domains: demographics11; barriers to par-
ticipation in behavioral weight management treatment19;
and preferences for behavioral weight management treat-
ment.7 Questions were presented in several forms, includ-
ing open ended, yes/no, multiple choice, and Likert rating
scales. The survey was administered as a one-time, 30-
minute telephone interview.
The Washington University School of Medicine In-
stitutional Review Board (St. Louis, MO) approved this
study. Verbal consent was obtained before the start of the
phone interview. To accommodate scheduling, the option
of completing the survey by phone outside of business hours
was offered.
Statistical Analyses
Data were analyzed using SPSS software (v.22; IBM
Corp., Armonk, NY). All available data from all partici-
pants were used. Descriptive statistics (mean, frequencies,
and proportions) were generated for survey responses.
Likert scale items were converted from severity to numeric
rating (e.g., 1= not at all; 3 = very much). Responses to
each survey question are reported as number (n) and per-
centage of caregivers with a response in each category for a
given question.
Results
Population Characteristics
A total of 91 youth were identified as being eligible for
the study, and the legal guardian documented in the med-
ical records for the child was contacted. After initial phone
contact, 26 adult caregivers agreed to participate (response
rate, 28.6%). Forty-eight adult caregivers were unable to
be contacted (n= 9 had numbers that were not in service or
were disconnected; n = 39 did not respond to multiple
voice messages). Seven adult caregivers declined to par-
ticipate (n = 4 reported they were ‘‘not interested’’ and
gave no other reason for declining; n= 3 declined because
of time constraints). Ten adult caregivers consented to
participate and began the survey, but were unable to com-
plete within the first contact and were unable to be contacted
thereafter. Demographic data were not obtained from adult
caregivers who were unable to be contacted or consented
for participation. Table 1 provides detailed information
regarding the characteristics of the respondents. In all cases,
the respondent was the youth’s legal guardian; 21 of 26
respondents who completed the survey were the youth’s
biological mother. The population was primarily privately
insured (n = 20) and mostly white (n= 22). There was a high
degree of parental educational attainment, with 18 of the 26
adult caregiver respondents having completed at least some
college and 6 respondents reporting graduate-level educa-
tion. Mean age of youth in question was 13.7 (standard de-
viation [SD], 4.4) years. The youths’ primary psychiatric
diagnoses were autism spectrum disorder (n= 13), ADHD
(n= 7), mood disorder (n= 2), anxiety disorder (n= 2), or
disruptive behavior disorder (n= 2). The majority of youth in
question achieved overweight or obese status (by BMI per-
centile) during antipsychotic treatment (n= 15; 57.6%),
Table 1. Respondent Characteristics
Primary diagnosis (n, %)
Autism spectrum disorder 13 (50.0)
ADHD 7 (26.9)
Mood disorder 2 (7.7)
Anxiety disorder 2 (7.7)
Disruptive behavior disorder 1 (3.8)
Other 1 (3.8)
Respondent’s relationship to child (n, %)
Mother 21 (80.8)
Other 5 (19.2)
Child’s race (n, %)
Caucasian 22 (84.6)
African-American 4 (15.4)
Child’s age (mean years, SD) 13.7 (4.4)
Weight status before starting antipsychotic (n, %)
Normal weight 15 (57.6)
Overweight or obese 11 (42.3)
Primary caregiver’s highest level of education (n, %)
High school/some college 8 (30.8)
College graduate/some graduate school 12 (46.1)
Graduate degree 6 (23.1)
Child’s principal residence (n, %)
Mother 15 (57.7)
Equally with mother and father 8 (30.8)
Father 1 (3.8)
Aunt/legal guardian 1 (3.8)
Supportive community 1 (3.8)
ADHD, attention deficit hyperactivity disorder; SD, standard
deviation.
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whereas the remainder of the population was overweight
or obese before starting antipsychotic medications (n= 11;
42.3%).
Identification of Weight Problems
and Treatment Referral
Of the 26 participating families, the majority of care-
givers recalled a healthcare provider initiating a discussion
about their child’s weight (81%; n = 21) and reported that
weight loss treatment was recommended (58%; n= 15);
half of caregivers (n = 13) reported receiving counseling
from a primary care provider (PCP). Additionally, 4 re-
ported being referred to a dietitian, 6 were referred to a
specific behavioral weight loss program available in the
community, 2 reported that their psychiatrist recommended
a medication change to decrease side effect of weight gain
related to medication, 1 reported being referred to an en-
docrinologist, and 1 reported being referred to see a ther-
apist. Families who received weight loss counseling from
their PCP indicated they were given recommendations to
decrease foods high in sugar and fat, increase consumption
of fruits and vegetables, and increase physical activity
(PA).
Of the 15 families who were referred for behavioral
weight loss treatment, 13 adult caregivers indicated their
level of motivation for participating in a weight loss pro-
gram with their child; the majority of respondents reported
high (61.5%; n = 8) or moderate (23.1%; n = 3) motivation
for weight loss. Despite this high reported initial rate of
Table 2. Reported Barriers to Participation in Weight Loss Treatment
What is the biggest barrier to participation in physical activity (N5 22)?
Barrier n (%) Representative quote
Child’s dislike of physical activity 9 (40.9) ‘‘It’s like world war three trying to get the iPad away from [him].’’
Symptoms of a physical or mental diagnosis preventing child
from participating in physical activity
8 (36.4) ‘‘[Her] weight makes it hard for her to be active.’’
‘‘[He] doesn’t get along with the other kids at recess because
of the autism.’’
Respondent’s lack of knowledge about safe/effective physical
activities for their child
4 (18.2) ‘‘I just wish someone would show me what to do. Is weight lifting
OK for kids who haven’t even gone through puberty yet?’’
Financial barriers limiting access to treatment program 1 (4.5) ‘‘We just don’t have the money to join a gym right now, and it
isn’t safe for the kids to play outside in our neighborhood.’’
What is the biggest barrier to maintaining a healthy diet for your child (N526)?
Barrier n (%) Representative quote
Excessive food intake 11 (42.3) ‘‘[He’ll] drink 60 oz of regular soda at a time.’’
Child’s preference for energy-dense or fast foods 8 (30.8) ‘‘Every time we pass a Taco Bell we have to stop.’’
Restrictive food preferences 2 (7.7) ‘‘I’ve tried all the tricks to hide veggies in things and [he]
always knows.’’
Difficulty meal planning 1 (3.8) ‘‘Everyone in the family wants something different so it’s
hard to plan.’’
Financial barriers 1 (3.8) ‘‘[Fresh produce] is so expensive. I could spend my whole
paycheck and it’ll go bad before anyone eats it.’’
None 3 (11.5)
What is the biggest reason for not starting, or starting but not completing a weight loss program (N5 21)?
Barrier n (%) Representative quote
Child’s physical or emotional health interfering
with participation
8 (38.1) ‘‘It’s just so stressful to talk about it. I don’t want [my son]
to feel deprived or ashamed.’’
Difficulty doing treatment related ‘‘homework’’
(e.g., logging foods, planning meals)
7 (33.3) ‘‘Homework for school was a battle already, so by the time
we got to the therapy homework everyone was too exhausted.’’
Financial barriers 4 (19.0) ‘‘My insurance doesn’t pay for ‘weight loss’ treatment. We
tried to see a dietitian but that wasn’t covered either.’’
Transportation difficulties 1 (4.8) ‘‘We have one car and [my husband] needs it to go to work.’’
Time commitment 1 (4.8) ‘‘We both work, and the other kids have activities after
school so we always missed appointments.’’
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motivation, only 5 of the 15 completed the weight loss
program to which they were referred. Two of the 11
families who were not referred to a weight loss program by
a healthcare provider sought weight loss treatment for their
child on their own; however, neither family completed the
treatment.
Perceived Barriers to Participation
in Weight Loss Treatment
Most (22 of 26) respondents indicated that it was either
moderately (36.4%; n = 8) or very (63.6%; n= 14) difficult
to ensure that their children engage in 60 minutes of PA per
day (Table 2).30 The primary reported barriers to partici-
pation in PA included child’s dislike of PA, followed
closely by concerns that symptoms of a physical or mental
diagnosis would prevent the child from participating in PA.
Specifically, adult caregivers reported difficulty introduc-
ing new, healthier foods and activities because of extreme
irritability, sensory problems limiting taste and PA pref-
erences, and social integration challenges preventing par-
ticipation in group physical activities. Less commonly
cited barriers included lack of knowledge about age-
appropriate and safe PAs for youth as well as financial
barriers limiting access to a treatment program. Perceived
barriers to maintaining a healthy diet included excessive
food intake, followed by preference for energy-dense, low-
nutrition foods and extreme resistance to the introduction
of healthier options. Difficulty planning ahead for shop-
ping and meal preparation and financial barriers limiting
access to healthy foods were also reported as barriers.
The 21 families who either did not start or did not
complete a weight loss program indicated that the most
pressing reason for this was concern that the child’s
physical or emotional health would interfere with partici-
pation in the program or increase the stress of participation.
The second most pressing reason for not starting or com-
pleting a program was related to concerns about the diffi-
culty of completing treatment-related homework, such as
keeping a daily food and activity log.
Reported Preferences for Weight Loss Treatment
Preferences for weight loss programming included in-
dividualized, prescribed plans for both meal planning and
for PA (Table 3). Caregivers noted that in-session exam-
ples and exposures to exercise and trying new foods would
be helpful, as would access to weight loss education and
support by an electronic interface, such as a website or
smartphone application. Caregivers also noted a preference
for adult support groups and/or group therapy sessions in
order to provide emotional and practical resources for
caregivers to implement behavioral changes in the home.
Discussion and Conclusions
This study is the first, to our knowledge, to report on
preferences for behavioral weight loss treatment in the un-
iquely vulnerable population of children with psychiatric
illnesses who are treated with antipsychotic medications. An
understanding of patient preferences for treatment, as well
as perceived barriers (including past negative treatment
experiences or failures) in at-risk populations is necessary
for facilitating shared decision making between healthcare
providers and their patients. This, in turn, can further inform
the development of effective and targeted behavioral in-
terventions to improve health outcomes.
The results of this study are consistent with other reports
of parental preferences and perceived barriers to health
behavior change,15,16,26 and additionally provide insight
Table 3. Reported Preferences for Weight Loss Treatment Programming
Preferences for weight loss treatment (N526)
What do you think would most likely make participation in a behavioral weight management program easier
for you and your child?
Characteristics n (%) Representative quote
Individualized, prescribed meal plans and shopping lists 10 (38.46) ‘‘Is there a way to eat what you like, not starve and
still lose weight?’’
Exercise support/demonstration alone 5 (19.23) ‘‘Maybe if some of the sessions included physical activity
[my son] would be more likely to try it.’’
Option for video conference appointments with provider 3 (11.54) ‘‘It would be so much easier to participate if we could Skype.’’
Access to weight loss education by an electronic interface
such as a website or smartphone application
3 (11.54) ‘‘Can’t someone figure out how to make an app that will help
get [my son] motivated to try new foods?’’
Food preparation assistance and support to try new foods 1 (3.85) ‘‘If you showed [my daughter] how to try new foods at an
appointment, maybe she would do it.’’
Group therapy sessions 1 (3.85) ‘‘I would like to know how other parents deal with this.’’
Flexible scheduling 1 (3.85) ‘‘Weekend appointments would be better.’’
None or missing 2 (7.69)
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into the factors that may enable versus hinder participation
in behavioral weight loss treatments in the population of
youth who are high weight and treated with antipsychotic
medications. First, we found that families reported a high
level of motivation to participate in a weight loss program,
but only a minority of families had completed treatment
recommended by a healthcare provider. Nonetheless, phy-
sician referral to weight management treatment appeared
to increase treatment enrollment compared to families who
self-referred, which is also consistent with reports that
healthcare provider recommendation to engage in weight
loss treatment is associated with greater motivation to
participate in treatment31 and increases the likelihood that
patients will engage in health behavior change.32 Second,
families indicated that primary barriers to participation in
or completion of a behavioral weight loss program were
mostly related to psychiatric diagnosis or symptoms, as
has been reported in adult mentally ill populations.20,21,33
Caregivers also frequently cited a preference for in-session
support to expose the child to new foods and PAs. Finally,
pragmatic challenges with time management, costs, and
transportation were cited as common barriers to partici-
pating in treatment.
These results support the current recommendations that
weight loss counseling be initiated by a healthcare provider.14
But perhaps more important, these results suggest that psy-
chiatric symptom severity contributes substantially to care-
giver perception of ability to successfully make behavior
changes in the home. Thus, an important future topic of re-
search in this area might include adaptation of existing parent-
focused pediatric weight loss interventions,34 which have the
potential to increase parent confidence and ability to initiate
health behavior changes. Additionally, a substantial minority
of psychiatrically ill youth were overweight or obese before
beginning antipsychotic treatment, suggesting that future be-
havioral weight loss interventions may be relevantly applied
to the broader population of youth with psychiatric illness, not
only to those treated with antipsychotic medications. Finally,
many caregivers noted pragmatic barriers to participation,
such as appointment availability and time constraints, as well
as the time and difficulty related to the homework involved in
most behavioral weight loss interventions (e.g., logging of
food intake and PA). These results are similar to those re-
ported in non–mentally ill obese pediatric populations,15,26
and suggest that potential strategies to decrease pragmatic
barriers to participation in the general population might also
be useful in the population of obese youth with psychiatric
conditions. These might include the use of telemedicine for
remote access to providers and use of mobile device appli-
cations to simplify treatment-related homework.
This study was subject to limitations. Specifically, this was
a small, single-site study of a primarily white and privately
insured population and does not include youth self-report of
barriers to and preferences for healthy eating and PA pro-
gramming from youth. Additionally, the survey did not assess
for disordered eating habits, such as binge eating, or body
shape and weight concerns, which are commonly comorbid
with psychiatric disorders.35 The presence of an undiagnosed
eating disorder (ED) could confound the results, given that
presence of an ED may impact preferences for and partici-
pation in behavioral weight loss treatment. Although this
study advances our knowledge regarding parental preferences
for weight loss interventions in mentally ill youth, the find-
ings should be replicated and extended in a larger, more
nationally representative sample, with both youth and parent
reports. Future studies should also assess for EDs and feeding
behaviors as potential barriers to participation in behavioral
weight loss interventions. Finally, results of the study may
have been subject to selection bias, which may have skewed
results of survey responses, given that adult caregivers will-
ing to participate in such a study may report different pref-
erences and barriers than parents who were not willing to
participate or who were unreachable. Survey nonresponse
was also a limitation in the present study; further research in
this area would optimally employ methods to improve survey
response rate, as well as obtain descriptive information
on survey nonresponders. These goals may best be accom-
plished by mobile technology-based research assessment,
given that this methodology is readily accessible and com-
monly accepted in demographically heterogeneous samples.
Such research is critical to clarify the targets and barriers for
obesity treatment and prevention efforts in mentally ill youth.
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